Compare Chevron Corp (CVX) vs Viatris Inc (VTRS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Chevron Corp vs Viatris Inc — how do they compare? Chevron Corp trades at $197.79 (market cap $385.65B), while Viatris Inc trades at $16.06 (market cap $18.49B). The key difference: Chevron Corp is far larger — about 20.9× Viatris Inc's market cap, and Chevron Corp pays the higher dividend (3.62%). Which is the better fit depends on your goals.
| CVX | VTRS | |
|---|---|---|
Market Cap | $385.65B | $18.49B |
Volume | 9,807,834 | — |
Sector | Energy | Health |
52-Week High | $211.14 | $17.86 |
52-Week Low | $146.72 | $9.49 |
Enterprise Value | $414.20B | $30.61B |
Dividend Yield | 3.62% | 2.98% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVX trades at $196.66, up 0.9% today, with a bullish technical signal supported by moving averages. The stock has beaten EPS estimates in recent quarters, though revenue and net income have declined from 2022 peaks. Analyst consensus is strongly bullish with a $214.25 price target, and the company maintains solid profitability with a 9.87% net margin and 12.25% ROE. Recent news highlights Chevron's $13.8 billion investment in Argentina's Vaca Muerta shale and geopolitical factors affecting oil prices.
Outlook remains positive driven by high oil prices and strategic investments, but risks include volatile energy markets and execution of large capital projects. The stock offers value with a P/E of 18.93 and consistent dividends, though investors face headwinds from declining profit margins and geopolitical tensions impacting global supply chains.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Chevron Corp
Chevron Corporation is an integrated energy company with operations in countries located around the world. The Company produces and transports crude oil and natural gas. Chevron also refines, markets, and distributes fuels, as well as is involved in chemical and mining operations, power generation, and energy services.
Read more on CVX →About Viatris Inc
Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →
